FDA Inspection 662690 — H & P Industries, Inc.

H & P Industries, Inc. — FEI 2128643

The FDA completed an inspection of H & P Industries, Inc. on May 18, 2010 in Hartland, WI. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 25 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
May 18, 2010
Fiscal Year
2010
Product Type
Devices
Project Area
Compliance: Devices
Location
Hartland, WI (United States)

Citations

IDCFRDescription
111121 CFR 211.25(a)Training , Education , Experience overall
117721 CFR 211.63Equipment Design, Size and Location
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
121521 CFR 211.67(b)Written procedures not established/followed
135821 CFR 211.100(b)SOPs not followed / documented
136121 CFR 211.100(a)Absence of Written Procedures
145121 CFR 211.113(b)Procedures for sterile drug products
145221 CFR 211.113(b)Validation lacking for sterile drug products
145621 CFR 211.115(b)Reprocessing/quality control unit
188321 CFR 211.165(a)Testing and release for distribution
189121 CFR 211.165(f)Failing drug products not rejected
191221 CFR 211.166(a)Written program not followed
202821 CFR 211.192Extent of discrepancy, failure investigations
203121 CFR 211.194(a)Complete test data included in records
312521 CFR 820.80(d)Lack of or inadequate final acceptance procedures
317221 CFR 820.198(c)Investigation of device failures
328621 CFR 820.90(b)(1)Procedures for product review,disposition lack of/inadequate
357021 CFR 211.100(a)Approval and review of procedures
360221 CFR 211.160(a)Deviations from laboratory control requirements
369621 CFR 820.100(b)Documentation
430321 CFR 211.67(b)Written procedures fail to include
435721 CFR 211.166(a)Results not used for expiration dates, storage cond.
54621 CFR 820.75(a)Lack of or inadequate process validation
63021 CFR 803.17Lack of Written MDR Procedures
79621 CFR 803.55(a)Initial Submission of Baseline Report